ATE252375T1 - Bioabbaubare mikropartikeln mit verzögerter wirkstofffreisetzung - Google Patents

Bioabbaubare mikropartikeln mit verzögerter wirkstofffreisetzung

Info

Publication number
ATE252375T1
ATE252375T1 AT98918424T AT98918424T ATE252375T1 AT E252375 T1 ATE252375 T1 AT E252375T1 AT 98918424 T AT98918424 T AT 98918424T AT 98918424 T AT98918424 T AT 98918424T AT E252375 T1 ATE252375 T1 AT E252375T1
Authority
AT
Austria
Prior art keywords
delayed release
biodegradable microparticles
relates
present
polymeric microparticles
Prior art date
Application number
AT98918424T
Other languages
English (en)
Inventor
Subodh Shah
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/843,975 external-priority patent/US6020004A/en
Application filed by Amgen Inc filed Critical Amgen Inc
Application granted granted Critical
Publication of ATE252375T1 publication Critical patent/ATE252375T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
AT98918424T 1997-04-17 1998-04-17 Bioabbaubare mikropartikeln mit verzögerter wirkstofffreisetzung ATE252375T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/843,975 US6020004A (en) 1997-04-17 1997-04-17 Biodegradable microparticles for the sustained delivery of therapeutic drugs
US6166598A 1998-04-16 1998-04-16
PCT/US1998/007856 WO1998046212A1 (en) 1997-04-17 1998-04-17 Biodegradable microparticles for the sustained delivery of therapeutic drugs

Publications (1)

Publication Number Publication Date
ATE252375T1 true ATE252375T1 (de) 2003-11-15

Family

ID=26741350

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98918424T ATE252375T1 (de) 1997-04-17 1998-04-17 Bioabbaubare mikropartikeln mit verzögerter wirkstofffreisetzung

Country Status (11)

Country Link
EP (1) EP0975334B1 (de)
JP (1) JP2002514215A (de)
AT (1) ATE252375T1 (de)
AU (1) AU7134898A (de)
CA (1) CA2287534C (de)
DE (1) DE69819145T2 (de)
DK (1) DK0975334T3 (de)
ES (1) ES2205481T3 (de)
HK (1) HK1022265A1 (de)
PT (1) PT975334E (de)
WO (1) WO1998046212A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2236700T3 (es) 1993-11-19 2005-07-16 Janssen Pharmaceutica N.V. 1,2-benzazoles microencapsulados.
US6291013B1 (en) 1999-05-03 2001-09-18 Southern Biosystems, Inc. Emulsion-based processes for making microparticles
WO2001030320A1 (en) * 1999-10-22 2001-05-03 Amgen Inc. Biodegradable microparticles with novel erythropoietin stimulating protein
DE60141680D1 (de) * 2000-01-14 2010-05-12 Univ Brown Res Found Verfahren zur herstellung von mikronisierte gefriergetrocknete partikeln
US7029700B2 (en) 2000-01-14 2006-04-18 Brown University Research Foundation Micronized freeze-dried particles
ES2382636T3 (es) 2000-10-31 2012-06-12 Surmodics Pharmaceuticals, Inc. Método para producir composiciones para la administración mejorada de moléculas bioactivas
DE60311801T2 (de) * 2002-05-02 2007-11-08 PR Pharmaceuticals, Inc., Fort Collins Zusammensetzungen aus östradiol-metaboliten mit kontrollierter freisetzung
EP1829529A1 (de) * 2002-05-03 2007-09-05 PR Pharmaceuticals, Inc. Zusammensetzungen zur kontrollierten Freisetzung von Estradiolmetaboliten
US9040664B2 (en) 2003-04-11 2015-05-26 Antriabio, Inc. Materials and methods for preparing protein-polymer conjugates
CN103432079A (zh) 2004-05-12 2013-12-11 巴克斯特国际公司 含有寡核苷酸的微球体及其在制备用于治疗1型糖尿病的药物中的应用
DK2072040T3 (da) 2004-05-12 2013-07-29 Baxter Healthcare Sa Terapeutisk anvendelse af nukleinsyremikrokugler
EP1679065A1 (de) * 2005-01-07 2006-07-12 OctoPlus Sciences B.V. Zubereitung mit kontrollierter Freisetzung von Interferon auf PEGT/PBT-Block-Copolymer-Basis
US8158152B2 (en) * 2005-11-18 2012-04-17 Scidose Llc Lyophilization process and products obtained thereby
MX2009001226A (es) 2006-08-04 2009-03-20 Baxter Int Composicion basada en microesferas para prevenir y/o revertir la diabetes autoinmune de nuevo inicio.
AU2008242842B2 (en) 2007-04-17 2014-06-05 Baxter Healthcare Sa Nucleic acid microparticles for pulmonary delivery
EP2271324A2 (de) * 2008-05-06 2011-01-12 Glaxo Group Limited Einkapselung biologischer wirkstoffe
US20110311630A1 (en) * 2008-06-09 2011-12-22 Boehringer Ingelheim International Gmbh Novel embedment particles for inhalation
KR20100037389A (ko) * 2008-10-01 2010-04-09 연세대학교 산학협력단 다중 약물방출조절이 가능한 솔리드 마이크로구조체 및 이의 제조방법
EP3484450A4 (de) * 2016-07-18 2020-04-01 Tissuegen, Inc. Verfahren und zusammensetzungen zur aufrechterhaltung der konformation und strukturellen integrität von biomolekülen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6058915A (ja) * 1983-09-12 1985-04-05 Fujisawa Pharmaceut Co Ltd 薬物含有脂質小胞体製剤
JP2653255B2 (ja) * 1990-02-13 1997-09-17 武田薬品工業株式会社 長期徐放型マイクロカプセル
WO1996022786A1 (en) * 1995-01-23 1996-08-01 Takeda Chemical Industries, Ltd. Sustained-release preparation and use

Also Published As

Publication number Publication date
DE69819145T2 (de) 2004-08-19
EP0975334B1 (de) 2003-10-22
ES2205481T3 (es) 2004-05-01
EP0975334A1 (de) 2000-02-02
JP2002514215A (ja) 2002-05-14
AU7134898A (en) 1998-11-11
DE69819145D1 (de) 2003-11-27
WO1998046212A1 (en) 1998-10-22
CA2287534A1 (en) 1998-10-22
DK0975334T3 (da) 2004-01-19
HK1022265A1 (en) 2000-08-04
PT975334E (pt) 2004-03-31
CA2287534C (en) 2004-12-28

Similar Documents

Publication Publication Date Title
ATE252375T1 (de) Bioabbaubare mikropartikeln mit verzögerter wirkstofffreisetzung
ATE321533T1 (de) Pharmazeutische zusammensetzungen mit verzögerter freisetzung für die parenterale applikation von hydrophilen wirkstoffen
BR9916053A (pt) Composições contendo um peptìdio e um ácido glicólico poliláctico, adequadas para preparação de implantes subcutâneos com perìodo de liberação prolongado
ATE387430T1 (de) Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe
PT1093819E (pt) Compostos e composicoes para fornecimento de agentes activos
TR200003787A3 (tr) Kararli yavas salimli oral dozaj bilesimi.
HK1036970A1 (en) Compounds and compositions for delivering active agents.
ATE251448T1 (de) Polyol/öl-suspensionen zur verzörgerten freisetzung von proteinen
IL153297A0 (en) Compounds and compositions for delivering active agents
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
BR0212921A (pt) Composição farmacêutica com base em fondant
HK1036969A1 (en) Compounds and compositions for delivering active agents
BR9804802B1 (pt) composição de liberação sustentada de drogas encapsuladas em micropartìculas de ácido hialurÈnico.
CY1111698T1 (el) Συνδυασμος που περιλαμβανει εναν ανταγωνιστη υποδοχεα ατ1 και εναν ενισχυτη εκκρισης ινσουλινης ή εναν ευαισθητοποιητη ινσουλινης
MY140724A (en) Novel arylethene-sulfonamides
WO2003028624A3 (en) Levothyroxine compositions and methods
DK1189615T3 (da) Endoparasiticid synergistisk kombination indeholdende cykliske depsipeptider og piperaziner
ATE208627T1 (de) Orale zusammensetzungen mit niedrigdosierten zytotoxischen proteinen
WO2003013441A3 (en) Levothyroxine compositions and methods
WO2004014318A3 (en) Levothyroxine compositions and methods
HUP0202630A2 (hu) Meiózisra ható anyagokat tartalmazó készítmények
BR0202759A (pt) Composição farmacêutica de liberação modificada contendo bupropiona como substância ativa
DE50311479D1 (de) Pharmazeutische zusammensetzung, enthaltend oxcarbazepin mit kontrollierter wirkstofffreisetzung
MXPA03007332A (es) Composiciones de levotiroxina y metodos para elaborar la misma.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0975334

Country of ref document: EP

REN Ceased due to non-payment of the annual fee